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Abstract
Scapinin, also named phactr3, is an actin and protein phosphatase 1 (PP1) binding protein, which is expressed in the adult
brain and some tumor cells. At present, the role(s) of scapinin in the brain and tumors are poorly understood. We show that
the RPEL-repeat domain of scapinin, which is responsible for its direct interaction with actin, inhibits actin polymerization in
vitro. Next, we established a Hela cell line, where scapinin expression was induced by tetracycline. In these cells, expression
of scapinin stimulated cell spreading and motility. Scapinin was colocalized with actin at the edge of spreading cells. To
explore the roles of the RPEL-repeat and PP1-binding domains, we expressed wild-type and mutant scapinins as fusion
proteins with green fluorescence protein (GFP) in Cos7 cells. Expression of GFP-scapinin (wild type) also stimulated cell
spreading, but mutation in the RPEL-repeat domain abolished both the actin binding and the cell spreading activity. PP1-
binding deficient mutants strongly induced cell retraction. Long and branched cytoplasmic processes were developed
during the cell retraction. These results suggest that scapinin enhances cell spreading and motility through direct
interaction with actin and that PP1 plays a regulatory role in scapinin-induced morphological changes.
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Introduction
The actin cytoskeleton is a vital component of a wide variety of
cellular and developmental processes such as cell adhesion, cell
migration, cell-cell interaction, and signal transduction [1–3]. Cell
migration is a critical step in tumor invasion and metastasis, and
regulation of this process could lead to therapies for treating
cancer [4]. During cell adhesion and migration, the actin
cytoskeleton is dynamically reorganized. Various kinds of actin
interacting proteins and Rho family GTPases play central roles in
actin cytoskeleton reorganization, such as the assembly and
disassembly of actin filaments in lamellipodia and filopodia [5–
7]. In addition, many studies have shown actin to be a component
of chromatin remodeling complexes, mRNP complexes, and RNA
transcription complexes [8–10].
Scapinin was initially identified as a PP1-binding protein that is
tightly associated with nuclear non-chromatin structures (the
nuclear matrix or nucleoskeleton) in HL-60 cells, a leukemia cell
line [11]. Scapinin was down-regulated in HL-60 cells during
differentiation induced by all-trans retinoic acid, an anti-tumor
drug. EST clone analysis revealed the presence of scapinin gene
transcripts in some cancer cells, for example lung and kidney
carcinomas [11]. However, in normal adult tissues, scapinin is
selectively expressed in the brain. At present, the role(s) of scapinin
in the brain and tumors are unknown.
Scapinin is a member of phactr/scapinin family, in which the
PP1-binding domain and the RPEL-repeat domain are highly
conserved. This family includes four members, phactr1, phactr2,
scapinin/phactr3, and phactr4 [12]. PP1 is a major eukaryotic
serine/threonine protein phosphatase that regulates diverse
cellular processes such as muscle contraction, glycogen metabo-
lism, neuronal signaling, and actin cytoskeleton organization [13–
15]. The catalytic subunit of PP1 binds to regulatory subunits that
are critical for substrate specificity and spatial control of PP1
within the cell. Allen et al. [12] demonstrated that the RPEL-
repeat domain of phactr1 is responsible for actin binding.
However, it remains unclear whether the RPEL-repeat domain
interacts with actin directly or indirectly.
The RPEL-repeat domain is composed of tandem repeats of
three RPEL motifs (pfam PF02755) and was initially identified as
an actin binding domain in megakaryocytic acute leukemia
protein (MAL) [16]. MAL is a transcriptional coactivator for
serum response factor (SRF), a transcription factor that activates
the mitogen-responsive genes. The dynamics of actin (assembly
and disassembly) control SRF activity by regulating the subcellular
localization of MAL (cytoplasm or nucleus) [16,17]. The RPEL-
repeat domain of MAL interacts with monomeric actin only. It
also works as a sensor for the actin monomer pool. The actin
monomer pool is controlled by extracellular growth stimuli such as
serum, through Rho family GTPase. Serum-activated Rho
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monomeric form to the filamentous form, and consequently
MAL loses actin monomers and accumulates in the nucleus.
To explore the function(s) of scapinin, we expressed scapinin in
cells and monitored their morphological changes. Scapinin
expression stimulated cell spreading and motility. Furthermore,
mutation experiments showed that both the RPEL-repeat domain
and the PP1-binding domain play crucial roles in these
morphological changes. Scapinin was colocalized with actin at
the edge of spreading cells. The RPEL-repeat domain of scapinin
directly interacts with actin and inhibits actin polymerization in
vitro. From these results, we propose a role for scapinin as a
regulator of actin cytoskeleton structures.
Methods
Antibodies and Whole Brain Lysate
Scapinin monoclonal antibody was developed as described [11].
Actin (clone AC-20) and GFP (M2) monoclonal antibodies were
purchased from Sigma. Anti-PP1 rabbit antibody was purchased
from Santa Cruz Technology Inc. (CA, USA). Human whole
brain lysate for SDS-polyacrylamide gel electrophoresis was
obtained from Clontech Laboratories Inc. (CA, USA).
Plasmid Construction and Mutation
The full-length scapinin cDNA was obtained by RT-PCR using
a RT primer 59-AATCTCTATGGCCTGTGGAA-39, a reverse
primer 59-TCTCTATGGCCTGTGGAATCT-39, a forward
primer 59-CTGGATGAGATGGACCAAACG-39, a template
poly A
+ RNA of HL-60 cells, and a high fidelity RNA PCR kit
(Takara, Japan). The 1.55 kb RT-PCR product was integrated
into SmaI site in pKF18k (Takara, Japan) and sequenced. The
BamHI/EcoRI fragment from pKF18k/scapinin was inserted into
BglII/EcoRI sites of pEGFP-c2 (Clontech) or into BamHI/EcoRI
sites of pcDNA3 (Invitorgen). Deletion and point mutants of
pEGFP-c2/scapinin were generated by PCR based mutagenesis as
described [11]. The Primers were designed according to the
sequence data of scapinin (accession number, AB098521).
Mutation in pEGFP-c2-scapinin was confirmed by sequencing.
The Expand High-Fidelity DNA polymerase (Roche Molecular
Biochemicals) was used for PCR.
Cell Culture and Transfection
Cos7 and Hela cells were cultured in Dulbecco’s modified
minimal essential medium (DMEM) containing 10% fetal bovine
serum, 100 units/ml penicillin, and 100 mg/ml streptomycin. One
day before transfection, cells were seeded on Lab-Tek 8-
chambered coverglass or slideglass (Nalge Nunc International).
0.1 mg of pEGFP-c2-scapinin and 0.3 ml of the transfection
reagent Fugene 6 (Roche Molecular Biochemicals) were mixed
and added to cell cultures (0.25 ml medium) according to the
manufacturer’s instructions. Transfected cells were cultured in
DMEM containing 0.5% fetal bovine serum after transfection.
Fluorescent cells were observed in the viable state by using a
fluorescent microscope, Axiovert S100 (Carl Zeiss Corporation).
In starvation/serum stimulation experiments, the concentration of
serum was reduced to 0.5% at 3 hours after transfection, and 10%
serum was added to the medium for serum stimulation.
Conditional Expression of Scapinin in Hela Cells
To establish Hela cell lines, in which scapinin expression is
inducible, we used a tetracycline-regulated mammalian expression
system, the T-Rex system (Invitrogen Life Technology). In this
system, scapinin expression is depressed in the absence of
tetracycline and is induced by the addition of tetracycline to the
culture medium. We transfected pcDNA6/TR coding repressor
proteins for the tetracycline operator to Hela cells and established
a cell line that constitutively produced repressors. We then,
transfected pcDNA4/TO/myc-His where the full-length scapinin
cDNA was inserted between the BamHI and EcoRI sites and
established in a Hela cell line. We did not use myc- or 6xhistidine-
tags in this study, thus any scapinin expressed was untagged. All
procedures in establishing cell lines were followed according to the
manufacturer’s instructions.
Proliferation Assay
Cell proliferation was measured by an MTT assay. Hela cells
established as above were plated at 1610
4 cells/ well in 96-well
plates and cultured with or without 0.1 mg/ml tetracycline. At
each time point, the number of viable cells was assessed by the
MTT assay according to the manufacturer’s instructions (Pro-
mega), and the absorbance was measured at a wavelength of
570 nm with a 96-well plate reader.
Wound Healing Assay
To measure cell motility, we used a wound healing assay. Hela
cells were cultured on 6-well plates (Falcon) until confluent. The
confluent monolayer cultures were treated with or without 0.1 mg/
ml tetracycline for 4 hours and were then wounded with a straight
scratch using a yellow pipette tip. After washing them three times
with serum-free DMEM, the wounded monolayer cultures were
further incubated with or without 0.1 mg/ml tetracycline in
DMEM containing 1% fetal bovine serum. To reduce cell growth,
the serum concentration was reduced to 1%.
Immunofluorescence Staining and Cell Spreading Assay
Scapinin-inducible Hela cells were grown on Lab-Tek 8-
chambered coverglass (Nalge Nunc International) and cultured
in the presence or absence of 0.1 mg/ml tetracycline to induce
scapinin expression. The cells were fixed with 3.7% formaldehyde
in phosphate buffered saline for 15 minutes at room temperature,
permealized with 0.2% Triton X-100 in PBS for 2 minutes, and
incubated with blocking solution (1% bovine serum albumin and
2% fetal bovine serum in PBS) for 15 minutes. The cells were then
incubated with 0.2 mg/ml anti-scapinin monoclonal antibody for
1 hour. Anti-scapinin monoclonal antibody was developed as
described [13]. After rinsing several times with PBS, the cells were
incubated with fluorescein isothiocyanate (FITC)-anti-mouse IgG
antibody and rhodamine-phalloidin for 30 minutes. This was
rinsed again in PBS, before viewing specimens under a fluorescent
microscope. To monitor the effect of scapinin on cell spreading,
scapinin-inducible Hela cells grown on dishes were trypsinised
with trypsin/EDTA and transferred to Lab-Tek 8-chambered
slideglass (Nalge Nunc International). To induce scapinin
expression, tetracycline was added to each chamber at a final
concentration of 0.1 mg/ml. At time points specified in the figures,
cell morphology was photographed randomly under a phase-
contrast microscopy and the percentage of adherent cells were
determined. We counted over 100 cells per chamber. We used
glass slides as opposed to plastic culture dishes because the
differences in cell spreading by scapinin expression were more
apparent. Parental and control (expressing no scapinin) Hela cells
adhere poorly to glassware.
Confocal Microscopic Observation
Scapinin-inducible Hela cells and GFP-scapinin-expressing
Cos7 cells were grown on Lab-Tek 8-chambered coverglass and
Scapinin and Actin Dynamics
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cells, the scapinin was stained with scapinin monoclonal antibody
(the first antibody). Alexa Fluor 488-conjugated goat anti-mouse
antibody (Molecular Probes) was used as the secondary antibody.
Actin was stained with rhodamine-phalloidin. The localization of
scapinin, GFP-scapinin, and actin was observed under a laser
scanning microscope LSM 5 EXCITER (Carl Zeiss MicroImaging
Inc.).
Measurement of Cell Area
Scapinin-inducible Hela cells grown on Lab-Tek 8-chambered
slideglass were cultured in the presence or absence of tetracycline
as described above. The cells were monitored and randomly
photographed. After printing the photographs, the cells were cut
out with a scalpel, and their weights were determined with a
quartz crystal microbalance (Sartorius, Germany). Cos7 cells that
expressed GFP or GFP-scapinin were randomly photographed
under a fluorescent microscope. Fluorescent Cos7 cells were cut
out of the printed photographs and weighed with a quartz crystal
microbalance as above. To calculate the cell area (mm
2) from
weights, the ruled 50650 m m area (2,500 mm
2) of a hemocytom-
eter was used as a standard.
Western Blotting and Densitometric Analysis
Western blotting was performed, and signals were detected by
enhanced chemiluminescence method (Amersham) as described
previously [11]. Chemiluminescence images were analyzed with
LightCapture AE-60-960 (ATTO, Japan).
GST Pull-Down Assay
The cDNA fragment of Scapinin coding RPEL repeat(s) was
amplified by PCR using a specific primer set, to which EcoRI
(forward primer) or SalI (reverse primer) recognition sequence
were added. The cDNA fragment was inserted into EcoRI/SalI
sites in pGEX-4T-1 (Amersham Biosciences). GST fusion proteins
were produced in E. coli BL21 (DE3) pLys and purified with
glutathione-sepharose (Amersham Biosciences). Each GST fusion
protein was conjugated to CNBr-activated sepharose at a protein
concentration of 5 mg/ml bed volume. HL-60 cells (2610
8) were
lysed in 0.5% Triton X-100/cytoskeleton buffer (10 mM Pipes
pH 6.8, 100 mM KCl, 2 mM MgCl2, and 0.5 mM EGTA)
including protease inhibitor cocktail and sonicated. The cell lysate
were separated by centrifugation at 10,000 g for 20 minutes and
incubated with GST fusion protein-conjugated sepharose beads
for 2 hours. After incubation, the beads were washed twice with
0.5% Triton X-100/cytoskeleton buffer and once with RIPA
buffer (0.1% SDS, 0.5% sodium deoxycholate, 1% Nonidet P-40,
50 mM Tris-HCl pH 8.0, 150 mM NaCl). RIPA buffer was used
to reduce non-specific binding of actin to sepharose beads. Finally,
proteins were extracted from the beads with SDS sample buffer
and were subjected to SDS acrylamide gel electrophoresis.
Co-immunoprecipitation Assay for Actin and PP1 Binding
GFP-scapinin plasmids were transfected into Cos7 cells
(,5610
5) grown on 100 mm dishes, and after 24 hours the cells
were suspended in 0.5% Triton X-100/cytoskeleton buffer
including protease inhibitor cocktail with the aid of sonication.
After centrifugation at 10,000 g for 15 mins, the supernatants
were incubated with anti-GFP antibody for 3 hours. Immuno-
complexes were collected with protein G-agarose beads that had
been washed twice with 0.5% Triton X-100/cytoskeleton buffer.
For the actin binding assay, after washing with 0.5% Triton X-
100/cytoskeleton buffer, protein G-agarose beads were washed
once with RIPA buffer to reduce the non-specific binding of actin
to agarose beads. Immunocomplexes were subjected to Western
blotting with anti-scapinin monoclonal antibody, anti-actin
monoclonal antibody, or anti-PP1 polyclonal antibodies.
Actin Polymerization
Actin polymerization was quantified in the presence of various
molar ratio of RPEL-GST. Skeletal muscle actin was purified from
dry rabbit muscle, and actin polymerization was measured by an
ultracentrifugation assay as described [18]. To polymerize actin, a
solution consisting of G-actin and GST-RPEL was adjusted to
produces final concentrations of 100 mM KCl, 2 mM MgCl2, and
10 mM Tris-HcCl (pH 7.8) and incubated at 20uC for 60 min.
After sedimentation at 130,000 g for 15 min, the supernatant and
pellet were subjected to SDS-PAGE. The peak areas of actin
bands in the supernatant and pellet were measured by a
densitometer (Fuji-Riken), and the fraction of depolymerized actin
(Fb) was calculated as Fb=S/(S+P).
The apparent affinity of RPEL-GST for actin was determined
by exploiting its ability to inhibit actin polymerization. The
dissociation constants (Kd) and number of RPEL binding sites of
actin (n) were calculated by nonlinear regression in Igor Pro
software (WaveMetrics, Oregon) using the following equation:
Fb~Fupz 1=2 ðÞ 1{Fup{Fud ðÞ At 1{Fup{Fud ðÞ
zX=nzKd{ ﬃ p At 1{Fup{Fud ð ðÞ zX=nz Kd ðÞ 2
{4At 1{Fup{Fud ðÞ X=nÞÞ= At 1{Fup{Fud ðÞ ðÞ
where At and X are the total actin and total GST-RPEL
concentrations, respectively. Fup and Fud indicate the fractions of
contaminated (denatured) actins that were unable to polymerize
even without GST-RPEL and unable to bind to GST-RPEL and
depolymerize, respectively. At and Fup are known values, and Fb
is a function of X.
Results
Domain Structure of Scapinin
Fig. 1 illustrates the domain structure of scapinin. The C-
terminal region was identified as a PP1-binding domain [11]. The
RPEL-repeat domain is composed of tandem repeats of three
RPEL motifs. The PP1-binding domain, RPEL-repeat domain,
and N-terminal region are highly conserved in the phactr/scapinin
family, suggesting important physiological roles for these domains.
RPEL-repeat Domain and Actin Binding
We applied the yeast two-hybrid method to determine scapinin-
binding proteins. We have previously determined PP1 as a binding
partner with this approach. After further analysis using the C-
terminal region (300–518 aa) as a bite, we obtained eight
independent clones that coded for b-actin cDNA (data not
shown). Three RPEL motifs are perfect fits for the consensus
sequence, RPxxxEL, of the RPEL motif (Fig. 1B). Deletion mutant
experiments demonstrated that phactr1 binds with actin through
the RPEL-repeat domain [12]. However, it is unclear whether the
RPEL-repeat domain interacts with actin directly or indirectly.
Several GST-RPEL constructs (Fig. 1C) were conjugated to
agarose beads and subjected to an in vitro pull-down assay with
HL-60 cell lysates (Fig. 1C). Cell lysates and GST-RPEL beads
were incubated in 0.5% Triton X-100/cytoskeleton buffer
(10 mM Pipes pH 6.8, 100 mM KCl, 2 mM MgCl2, and
0.5 mM EGTA). To reduce the non-specific binding of actin to
Scapinin and Actin Dynamics
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samples) were washed twice with 0.5% Triton X-100/cytoskeleton
buffer and once with RIPA buffer (0.1% SDS, 0.5% sodium
deoxycholate, 1% Nonidet P-40, 50 mM Tris-HCl pH 8.0,
150 mM NaCl). Without a stringent wash with RIPA buffer,
substantial amounts of actin were nonspecifically co-precipitated
with the agarose beads. Scapinin-RPEL constructs of 350–468 aa
and 350–422 aa bound with actin in vitro, but a single RPEL motif
construct (350–385 aa) showed no actin-binding activity (Fig. 1C).
It is documented that MAL loses its actin-binding activity after
double mutations at two arginine residues (RR33/77DD) or two
proline residues (PP34/78AA) of the PREL-repeat domain [16].
Guettler et al. [19] showed that single RPEL mutations (R.Ao r
P.A) of the MAL-RPEL-repeat domain affect its subcellular
localization and transcriptional cofactor activity, demonstrating
that the integrity of all three RPEL motifs is required for MAL
regulation. Next, we introduced mutations into the second motif of
the scapinin-RPEL-repeat domain (RP.AA mutant). The
RP.AA mutant exhibited no actin binding activity (Fig. 1C).
As the GST-RPEL construct of 350–465 aa is highly insoluble,
only ,30% of them were recovered from E. Coli, and the purified
samples included substantial amounts of cleaved polypeptides
(Fig. 1C). Furthermore, more than half of the purified polypeptides
were precipitated during dialysis against actin polymerizing buffer.
At present, the reason for the insolubility of this construct is
unknown.
Inhibition of Actin Polymerization by the RPEL Repeats of
Scapinin in vitro
The GST-RPEL construct of MAL interacts with purified
skeletal muscle actin and inhibits actin polymerization in vitro [20].
Next, we tested whether the GST-RPEL construct of scapinin has
the same properties as the MAL construct. The GST-RPEL
Figure 1. Interaction of the RPEL repeats of scapinin with
cellular actin. (A) The primary structure of scapinin. The N-terminal
region that is conserved in the scapinin/phactr family (NC), the proline-
rich region (PR), the three tandem repeats of PREL motifs (RPEL repeats
1, 2, and 3), and the PP1-binding domains (PP1) are indicated. In
addition to the N-terminal conserved region (NC), the RPEL-repeat and
PP1-binding domains are highly conserved in the scapinin/phactr
family. (B) Three RPEL motifs are compared. The RPEL motif (pfam
PF02755) is named according to the conserved amino acid sequence,
RPxxxEL. (C) Interactions between the RPEL repeats of scapinin and
cellular actin. The RPEL repeats of scapinin were produced as fusion
proteins with glutathione S-transferase (GST) in E. Coli as illustrated. In
the RP.AA mutant, both the arginine and proline residues in the
second motif of the RPEL repeats were substituted with alanine
residues. Purified GST-RPEL constructs were separated by SDS-
polyacrylamide gel electrophoresis and stained with coomassie brilliant
blue (CBB). GST-RPEL constructs were covalently conjugated to CNBr-
agarose beads (5 mg protein/ml bed volume) and subjected to a pull-
down assay with HL-60 cell lysates (see ‘Methods’). Actin in the pull-
down-samples was determined by Western blotting (WB) with anti-
actin antibody. The GST-RPEL construct (350–465 aa) contained
substantial amounts of cleaved products (see ‘Results’).
doi:10.1371/journal.pone.0004247.g001
Figure 2. The RPEL repeats of scapinin interact with purified
skeletal muscle actin and inhibit actin polymerization in vitro.
(A) GST or GST-RPEL repeats (350–422 aa) were covalently conjugated
to CNBr-agarose beads (as in Figure 1C) and were incubated with
purified skeletal muscle actin. After washing with RIPA buffer (0.1% SDS,
0.5% sodium deoxycholate, 1% Nonidet P-40, 50 mM Tris-HCl pH 8.0,
150 mM NaCl), bound proteins were eluted with SDS sample buffer,
separated by SDS-polyacrylamide gel electrophoresis, and stained with
coomassie brilliant blue (CBB). GST and GST-RPEL proteins (shown by a
asterisk) were partly released from the beads by elution with SDS
sample buffer. (B) Inhibition of actin polymerization by the RPEL
repeats. Skeletal muscle actin (18 mM) was incubated with GST- RPEL
repeats (350–422 aa) or GST at the indicated concentrations to
polymerize at room temperature for 30 minutes, and then filamentous
actin (P) and monomeric actin (S) were separated by ultracentrifugation.
Aliquots were analyzed by SDS polyacrylamide gel electrophoresis and
stained with coomassie brilliant blue (CBB). Since the contamination of
supernatants in the pellet fraction was technically inevitable, a small
portion of GST-RPEL construct was seen in the pellet. (C) The density of
each actin band was measured by a densitometer and plotted.
doi:10.1371/journal.pone.0004247.g002
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actin polymerizing buffer, and the purified samples included
substantial amounts of cleaved polypeptide (see above). Thus, we
used the GST-RPEL construct of 350–422 aa for further studies.
The GST-RPEL construct of 350–422 aa bound to purified
skeletal muscle actin (Fig. 2A), demonstrating that the RPEL-
repeat domain of scapinin directly interacts with actin without
additional accessory proteins.
Next, we examined the effect of the GST-RPEL construct on
actin polymerization using an ultracentrifugation method [18]. As
the GST-RPEL construct was increased, filamentous actin (the
pellet fraction) was reduced, demonstrating that the RPEL repeats
inhibit actin polymerization (Fig. 2B). Although a small amount of
GST-RPEL polypeptides were seen in the pellet fraction (Fig. 2B),
this was due to contamination of the soluble fraction as it is
difficult to completely remove soluble proteins from the pellet
fraction after ultracentrifugation.
Actin monomer binding proteins such as DNase I, gelsolin,
profilin, cofilin, and thymosins induce the depolymerization of
actin in vitro. We can assume that the amount of GST-RPEL
necessary for depolymerization is equal to that of GST-RPEL
bound to actin monomer [21]. Posern et al. [20] determined the
dissociation constant of MAL-RPEL-actin complex from a
titration with MAL-RPEL for the fluorescence intensity of
pyrene-labeled actin, which is an indicator of depolymerization.
According to this report, we have determined the apparent
dissociation constant of scapinin-RPEL–actin complex from the
titration with scapinin-RPEL for the fraction of depolymerized
actin (Fig. 2C). Increasing the scapinin-RPEL led to saturation of
actin depolymerization at a stoichiometric concentration. The
data were consistent with a stoichiometry for scapinin-RPEL to
actin of 1.2160.16 and an apparent dissociation constant of
0.01860.26 mM( 6uncertainty of the fit). These results suggest
that the RPEL repeats (359–422 aa) of scapinin interact with actin
monomers, but not with actin filament.
Recently Guettler et al. [19] showed that single RPEL motifs
(RPEL1, RPEL2, RPEL3) of the MAL-RPEL-repeat domain
interact with actin. RPEL1, RPEL2, and RPEL3 of MAL bind
with actin with apparent dissociation constants of ,5.4 mM,
,2.3 mM, and ,18.8 mM, respectively. However, a single RPEL
motif (350–385 aa) of scapinin showed no actin binding activity
(Fig. 1C). A stringent washing step (RIPA buffer) was included in
our binding assay to reduce non-specific binding of actin to
agarose beads (Fig. 1C). Thus, the discrepancy may due to
differences in the assay conditions.
Stimulation of Cell Spreading and Motility by Scapinin
Expression
For comprehensive studies, we established a Hela cell line in
which scapinin expression was induced by the addition of
tetracycline. Scapinin expression levels in Hela cells at 0.1 mg/ml
teracycline were almost comparable to those in the human brain
(Fig. 3A). In the human brain, an additional polypeptide (shown by
an asterisk) is seen in Western blots with anti-scapinin antibody. This
additional polypeptide seems to be a variant form (559 aa) of
scapinin (accession number, NP_542403). We obtained essentially
the same results for cell proliferation, cell spreading, and cell motility
at both 0.1 and 1 mg/ml tetracycline (see below). Data from 0.1 mg/
ml tetracycline are presented here unless otherwise stated.
We examined the effect of scapinin on cell proliferation. Scapinin
expression at 0.1 mg/ml tetracycline did not significantly affect the
growth rate of Hela cells (Fig. 3B). Even at 1 mg/ml tetracycline, no
significant differences were detected between scapinin-expressing and
non-expressing cells. This result demonstrates that scapinin expres-
sion neither stimulates nor inhibits cell proliferation in Hela cells.
Cell spreading was significantly enhanced by expression of
scapinin (Fig. 4A). Scapinin-expressing cells adhered to glassslides
faster than non-expressing cells (Fig. 4B). Next we measured cell
area of adherent cells at 20 hours. To focus on adherent cells,
rounded cells were excluded from this measurement. Cell area of
Figure 3. Induction of scapinin expression in Hela cells and its effect on cell proliferation. (A) Tetracycline-induced expression of scapinin
in Hela cells. Hela cells were cultured with tetracycline at the indicated concentrations for 24 hours. Cell lysates were separated by SDD-
polyacrylamide gel electrophoresis, and scapinin expression levels were measured with Western blotting using anti-scapinin monoclonal antibody.
Human whole brain lysate (Clontech Laboratories Inc.) was also loaded. Twenty microgram proteins were applied to each lane. Scapinin expression
levels of Hela cells were expressed as folds against the whole brain lysate. (C) The effect of scapinin on the proliferation of Hela cells. Hela cells were
plated at 1610
4 cells/ well in 96-well plates and cultured with (open bars) or without (closed bars) 0.1 mg/ml tetracycline. At each time point, the
number of viable cells was assessed by an MTT assay, and the absorbance was measured at a wavelength of 570 nm with a 96-well plate reader. Data
are expressed as mean6SEM of four separate experiments.
doi:10.1371/journal.pone.0004247.g003
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(Tet+) cells were 586653 mm
2 and 883695 mm
2 (mean6SD,
n=50), respectively. Cell spreading of parental Hela cells was not
enhanced by tetracycline treatment (Fig. 4B). Notably, scapinin-
expressing cells frequently exhibited elongated shapes that were
rarely seen in the parental Hela cells used in this study.
We assessed the effect of scapinin expression on cell motility
using a wound healing assay. The expression of scapinin markedly
enhanced cell motility (Fig. 4C). To reduce cell growth, we
performed the wound healing assay with 1% fetal bovine serum. It
is notable that whereas non-expressing cells (Tet2) collectively
moved, scapinin-expressing cells (Tet+) migrated as single cells
(Figure 4D).The parental Hela cells used in this study moved in
sheet-like structures like the non-expressing cells. The cell motility
of the parental cells was not enhanced by tetracycline treatment.
Colocalization of Scapinin with Actin at the Edge of
Spreading Cells
Immunostaining showed that scapinin and actin were mostly
colocalized at the edges of spreading cells (Fig. 5A). Confocal
Figure 4. Enhancement of cell spreading and motility by scapinin. (A) Enhancement of cell spreading by scapinin. Inducible Hela cells were
seeded onto an 8-chambered glass-slide and then cultured with (Tet+) or without (Tet2) 0.1 mg/ml tetracycline. Cell morphology was monitored with
a light microscope and photographed at 12 hours. (B) Inducible Hela cells were treated as in (A), and cell morphology was monitored at specified
times. Adherent and non-adherent cells were counted under a microscope. Data are expressed as mean6SED from four independent experiments.
Student’s t test: *: P,0.05; **: P,0.01. The parental Hela cells were also cultured with (Tet+) or without (Tet2) of tetracycline, and cell morphology
was monitored. (C) Enhancement of cell motility by scapinin. To measure cell motility, we used a wound healing assay. Hela cells were cultured on 6-
well plates until confluence. The confluent monolayer cultures were treated with (Tet+) or without (Tet2) 0.1 mg/ml tetracycline for 4 hours and were
then wounded with a straight scratch using a yellow pipette tip. After washing them three times with serum-free DMEM, the wounded monolayer
cultures were further incubated (Tet+) with or without (Tet2) 0.1 mg/ml tetracycline in DMEM containing 1% fetal bovine serum. To reduce cell
growth, the serum concentration was reduced to 1%. At 1, 24, and 48 hours after the wounding, the cell monolayer was photographed. The front of
cell migration at 24 hours was shown in (D).
doi:10.1371/journal.pone.0004247.g004
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and actin (Fig. 5B). Shortly after tetracycline-treatment, when
scapinin expression levels were low, actin stress fibers were seen in
some cells, but as scapinin expression levels were increased, the
number of actin stress fibers was reduced (Fig. 5C). In addition,
scapinin staining was not seen in actin stress fibers (Fig. 5C). These
results suggest that scapinin promotes cell spreading and motility
through reorganization of the actin cytoskeleton.
Scapinin was predominantly distributed in the cytoplasm at all
serum concentrations tested (0.5,15%). MAL translocates from
the cytoplasm to the nucleus upon serum stimulation (15% FBS)
after starvation (0.5% FBS) [16]. In contrast to MAL, scapinin
exhibited no significant cytoplasm-to-nucleus translocation upon
serum stimulation after starvation.
GFP-scapinin Induced Cell Spreading in Cos7 Cells
The expression of proteins fused to GFP has made it possible to
localize and study the dynamics of living cells. Expression of GFP-
scapinin (wild type) also induced cell spreading in Cos7 cells
(Fig. 6A and B). Cell area of adherent cells of GFP-expressing
(Tet2) and GFP-scapinin-expressing (Tet+) cells were
777673 mm
2 and 15766221 mm
2 (mean6SD, n=50) respective-
ly. In Cos7 cells, GFP-scapinin was predominantly distributed
throughout cells. Notably, GFP-scapinin was frequently distribut-
Figure 5. Distribution of scapinin and actin in Hela cells. (A) Hela cells grown on glass coverslips were cultured in the presence (Tet+)o r
absence (Tet2) of 0.1 mg/ml tetracycline and were then fixed at 20 hours. After permeabilization, the distribution of scapinin and the actin
cytoskeleton were visualized by staining with anti-scapinin antibody (green) and rhodamine-phalloidin (red), respectively. Scapinin and actin are
colocalized (arrows). (B) Confocal microscopic observation. Hela cells were cultured in the presence of 0.1 mg/ml tetracycline for 20 hours and were
then stained with anti-scapinin antibody (green) and rhodamine-phalloidin (red) as in (A). Scapinin and actin are colocalized (arrows). Bar: 20 mm. (C)
Absence of scapinin in actin stress fibers. Hela cells grown on a glass coverslip were cultured in the presence of 0.1 mg/ml tetracycline and were then
fixed at 8 hours. The distribution of scapinin and the actin cytoskeleton were visualized by staining with anti-scapinin antibody (green) and
rhodamine-phalloidin (red), respectively as (A). There are four cells; two cells express low levels of scapinin (asterisks), and the other two cells express
high levels of scapinin (arrow heads). Bar: 20 mm.
doi:10.1371/journal.pone.0004247.g005
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microscopy revealed colocalization of GFP-scapinin and actin in
ruffle-like structures (Fig. 6D). This result indicated that GFP-
scapinin is localized in actin-based ruffles. In only a small number
of cells (less than 15%), distinctive GFP-scapinin signals were seen
in the nucleus.
The Roles of the RPEL-repeat and PP1-Binding Domains
in Cell Spreading
Two approaches using a transient expression system (Fig. 6) and
a tetracycline-induced expression system (Fig. 4) gave essentially
identical results with respect to cell spreading. To explore the roles
of the RPEL-repeat and PP1-binding domains, we made actin-
binding and PP1-binding deficient mutants and tested their ability
to stimulate cell spreading. The deletion and point mutants used in
this study are shown in Fig. 7A, and interactions of each GFP-
scapinin mutant with endogenous actin and PP1 were examined
by a co-immunoprecipitation assay (Fig. 7B).
A mutant without the PP1-binding domain (D469–518)
induced cell rounding or shrinkage instead of cell spreading.
Notably, cell rounding and shrinkage were accompanied by
development of long and branched cytoplasmic processes. Allen
et al. [12] demonstrated that replacement of phenylalanine
residue (F) with alanine (A) in this C-terminal region impairs the
PP1-binding activity of Phactr1. We mutated the phenylalanine
residue of scapinin essential for PP1 binding to alanine (F515A).
This point mutant showed essentially the same results as the
D469–518 mutant (Fig. 7C). These PP1-binding deficient
mutants retained interactions with endogenous actin (Fig. 7B).
These results suggest that the PP1-binding domain plays a
regulatory role in the morphology changing-activities of
scapinin.
Time course of morphological changes induced by a PP1-
binding deficient mutant of F515A showed that, at early times
(6 hours) after transfection, some cells expressing F515A mutant
showed spread morphologies like wild-type scapinin expressing
cells, but they promptly shrank to show rounded morphologies
with long and branched cytoplasmic processes (Fig. 8). We
obtained the same results with D469–518 mutant. PP1-binding
deficient mutants may strongly induce cell retraction although they
retain the cell spreading activity.
Further deletion of the C-terminal region including the three
RPEL motifs (D359–518) completely abolished the morphology-
changing activities (Fig. 7C). D359–518 deletion mutants abolished
both actin and PP1 binding activities (Fig. 7B)
As shown in Fig. 1C, double mutations (RP.AA) in the second
RPEL motif of the RPEL-repeat domain abolished actin-binding
in vitro. Then, we introduced mutations into the second motif of the
RPEL repeat, the RP.AA mutant, in which both arginine (407)
and proline (408) residues have been replaced with alanine
(Fig. 7B). As with the D359–518 deletion mutant, the RP.AA
mutant exhibited no morphology-changing activities (neither cell
Figure 6. GFP-scapinin-induced morphological changes in Cos7 cells. pEGFP empty vectors (A) and pEGFP-scapinin (B) were transfected into
Cos7 cells, and the cells were cultured for 16 hours. The cell morphology and the distribution of GFP-scapinin were monitored with fluorescent
microscopy and photographed. (C) The distribution of GFP-scapinin in ruffles. (D) Colocalization of scapinin and actin in ruffles. Cos7 cells expressing
GFP-scapinin were fixed at 16 hours and then stained with rhodamine-phalloidin (red) to visualize actin. Localization of GFP-scapinin (green) and
actin (red) was observed with a confocal microscopy. Ruffles were shown by arrows. Bars: 20 mm.
doi:10.1371/journal.pone.0004247.g006
Scapinin and Actin Dynamics
PLoS ONE | www.plosone.org 8 January 2009 | Volume 4 | Issue 1 | e4247spreading nor cell rounding) in Cos7 cells. Accordingly, the RPEL-
repeat domain and its actin-binding activity are essential for
morphological changes.
Discussion
Actin cytoskeleton dynamics play essential roles in cell adhesion,
cell motility, and cell morphology. Tetracycline-induced expression
of scapinin in Hela cells enhances cell spreading and motility at
expression levels comparable to those in the human brain (Fig. 3A
and 4). In Hela cells, scapinin colocalizes with actin at the edge
(maybe the lamellipodiim, ruffle, or filopodium) of spreading cells
(Fig. 5). Notably, actin stress fibers were seen in cells expressing
lower levels of scapinin, but their number was decreased in cells
expressing higher levels of scapinin (Fig. 5). In addition, scapinin-
staining was hardly seen in actin stress fibers (Fig. 5). It seems that
scapinin expression reduces the number of actin stress fibers and
increases the amount of peripheral actin. Mutations in the RPEL-
repeat domain abolished both the actin-binding and morphology-
changing activities of scapinin (Fig. 7). These results demonstrate
that scapinin can modulate actin cytoskeleton structures and
thereby enhance cell spreading and motility.
The RPEL-repeat domain of scapinin interacts with purified
skeletal muscle actin without any accessory proteins (Fig. 2A).
Mutations in the RPEL-repeat domain abolished both the actin-
binding and morphology-changing activities of scapinin (Fig. 1C
and 7). These results clearly demonstrate that direct interactions
with actin through the RPEL-repeat domain are essential for
scapinin-induced morphological changes.
It is known that the RPEL-repeat domain of MAL interacts with
actin monomers, but not with actin filaments [16]. The GST-RPEL
construct of MAL inhibits actin polymerization in vitro, supporting
the fact that the RPEL-repeated sequence is an actin-monomer-
binding motif [20]. The consensus amino acid sequence of RPEL
motifs , RPxxxEL, is conserved in the scapinin-RPEL-repeat
domain (Fig. 1B). Our in vitro study demonstrated that the GST-
RPEL construct of scapinin inhibits actin polymerization like that of
MAL (Fig. 2B and C). This result suggests that the RPEL-repeat
domain of scapinin like MAL may interact with actin monomers,
but not with actin filaments. Further studies are required to
determine the exact mode of actin-scapinin interactions.
Various kinds of actin-monomer-binding proteins play regula-
tory roles in actin dynamics, i.e., disassembly and assembly, and
thereby govern cell adhesion, cell motility, and cell morphology
[22]. For example, although profilin and ADF/cofilin were
initially identified as an actin-monomer-sequestering protein and
an actin-depolymerizing factor respectively, it is now established
that they play central roles in directional actin-filament growth, or
‘treadmilling’ as it is also known [5–7]. Wiskott-Aldridge syndrome
protein (WASP) homology domain 2 (WH2) is a small and
widespread actin-monomer-binding motif. WH2 has versatile
regulatory functions in actin dynamics [23,24]. Among WH2
containing proteins, whereas b-thymosins sequester actin mono-
mers during polymerization, WASP family proteins (WASP, N-
WASP, and WAVE) activate Arp2/3-dependent actin nucleation
and branching in respond to signals mediated by Rho-family
GTPase [25–27]. WASP and N-WASP interact with Arp2/3
complex through the C-terminal acidic region. Further biochem-
ical and structural studies are required to determine the exact
mode of actin-scapinin interaction by which scapinin enhances cell
spreading and motility. However, we do not exclude the possibility
that scapinin partly modulates cell morphology at the transcrip-
tional level, increasing or decreasing particular proteins to regulate
actin dynamics.
In contrast to scapinin, MAL induces no cell morphological
changes after the transfection of expression plasmids into cells
(personal communication, Dr. Treisman R.). Favot et al. [28]
reported that, when phactr/scapinn family proteins (they named
them PPEL proteins) were expressed as GFP fusion proteins in
cells, all four family members modified the shape of cells so that a
rough appearance at the edges of cells and various lengths of hair-
like cytoplasmic extensions were observed. In addition, they also
reported that all four members were predominantly distributed in
the cytoplasm. Their results are in good agreement with ours and
indicate that the cell morphology changing activity is a common
feature of all four members of the phactr/scapinin family.
This study suggests that scapinin can enhance cell spreading
and motility through interactions with actin cytoskeletons. EST
clone analysis demonstrated the presence of scapinin gene
transcripts in some tumors cells such as lung and kidney
carcinomas. Cell migration is a critical step in tumor invasion
and metastasis, and regulation of this process will lead to therapies
for treating cancer [4]. Further studies on the expression profile of
scapinin in various types of tumor cells and the relationship of
scapinin expression levels with malignancy are necessary.
Figure 7. The roles of the RPEL-repeat and PP1-binding
domains in scapinin-cell spreading. (A)T h ep E G F P - s c a p i n i n
mutants used in this study are illustrated. (B) Each construct shown in
(A) was transfected into Cos7 cells. The cells were cultured for 24 hours
and lysed in 0.5% Triton X-100/cytoskeleton buffer at 24 hours. GFP-
scapinins were immunoprecipitated with anti-GFP antibody, and
immunocomplexes were collected with protein A-agarose beads,
washed, and subjected to Western blotting with anti-scapinin
monoclonal antibody, anti-actin monoclonal antibody, and anti-PP1
polyclonal antibodies, respectively. (C) Each pEGFP-scapinin mutant was
transfected into Cos7 cells. Cells were cultured for 16 hours and then
monitored under a fluorescent microscope and photographed. Bar:
20 mm.
doi:10.1371/journal.pone.0004247.g007
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that regulates diverse cellular processes such as muscle contraction,
glycogen metabolism, neuronal signaling, and actin cytoskeleton
organization [13–15]. The catalytic subunit of PP1 binds to
regulatory subunits that are critical for substrate specificity and
spatial control of PP1 within the cell. PP1-binding deficient
mutants (D469–518 and F515A) induced cell rounding with
extensive development of long cytoplasmic processes instead of cell
spreading (Fig. 7). This result demonstrates that PP1 plays a
regulatory role in scapinin-induced morphological changes.
It was reported that the humpty dumpty mouse mutant phenotype
with failure to close the neural tube and optic fissure is caused by a
missense mutation in phacrt4 (a member of the phactr/scapinin
family), and interestingly, the missense mutation specifically
disrupts binding to PP1 [29]. This demonstrates that the PP1-
binding activity of phactr4 is critical for its physiological role in
embryogenesis. Our data also demonstrate that the PP1-binding
activity of scapinin is critical for the biological activity of scapinin
(Fig. 7).
The humpty embryos display elevated proliferation and abnor-
mally phosphorylated, inactive PP1, resulting in RB hyperpho-
sphorylation and derepression of E2F targets. We initially
identified scapinin as a component of the nuclear nonchromatin
structures (nuclear matrix or nucleoskeleton) in HL-60 cells and
found that scapinin is down-regulated during differentiation
induced by all-trans retinoic acid treatment (an anti-tumor drug).
Recently numerous studies have established the presence of actin
in the nucleus and have shown that actin is involved diversely in
nuclear activities including gene transcription, chromatin remod-
eling, and nucleocytoplasmic trafficking [8–10,17]. In addition to
actin, actin binding and adhesion proteins are present in the
nucleus and modulate nuclear functions [30]. We currently
hypothesize dual roles for scapinin in the cytoplasm and nucleus.
The scapinin/phactr3 gene has four leader exons, implying that
regulation of its gene expression may be complicated [31]. Down-
regulation of gene expression by RNAi is a powerful tool for
studying the physiological roles of many genes. Our attempts to
explore the functions of scapinin with RNAi have not yet
succeeded. The presence of multiple leader exons in the scapinin/
phactr3 gene may make it difficult. Further genetic studies are
necessary to determine the roles of scapinin in cell proliferation
and morphogenesis of normal neuronal tissues.
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